- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Atopic dermatitis
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Nemolizumab – July 2025
Nemolizumab; Powder for injection containing nemolizumab 30 mg with diluent in pre-filled dual-chamber pen; Nemluvio®
Last updated
9 July 2025